Test Price
2,400 AED✅ Home Collection Available
Beta Thalassemia HBB Full Gene Trio Analysis (Couple & Prenatal) in UAE | 2400 AED | 2026 DHA Guidelines
تحليل بيتا ثلاسيميا - فحص جين HBB الكامل (ثلاثي) في الإمارات | 2400 درهم | معتمد من هيئة الصحة بدبي
🔬 Guaranteed Diagnostic Precision
99.9% diagnostic sensitivity via ISO‑certified Sanger sequencing of the entire HBB gene in trio (both parents and fetus). All results clinically validated by DHA‑licensed specialists.
📦 Premium Cold‑Chain Home Collection
Hospital‑grade VIP mobile phlebotomy service (8 AM – 11 PM) with ISO‑certified cold‑chain transport of amniotic fluid, chorionic villi, cord blood, or peripheral blood.
📞 Telephonic Post‑Test Guidance
Confidential consultation with a clinical expert to interpret results, discuss clinical correlation, and plan next steps.
🛡️ Direct Insurance Billing
WhatsApp your insurance card to +971545488731 for immediate verification and pre‑authorization.
نضمن تحليلًا جينيًا ثلاثيًا كاملًا لجين بيتا ثلاسيميا بدقة تشخيصية عالية، يُجرى بواسطة سلسلة سانجر في مختبر معتمد لدى هيئة الصحة بدبي، مع خدمة سحب منزلي متكاملة وتوجيه سريري بعد النتيجة.
Comprehensive Trio HBB Gene Analysis – When Early Prevention Saves Generations
The Beta Thalassemia HBB Full Gene Trio Analysis is the definitive molecular test for couples planning a pregnancy or undergoing prenatal diagnosis. It simultaneously sequences the complete HBB gene in both parents and the fetal sample (amniotic fluid, chorionic villi, or cord blood) using gold‑standard Sanger sequencing, identifying all known pathogenic mutations that cause beta‑thalassemia. This trio approach provides a complete genetic risk profile, enabling informed reproductive decisions within the UAE’s advanced healthcare framework under DHA guidelines 2026.
| Feature | Our Trio HBB Full Gene Analysis | Standard Hemoglobin Electrophoresis |
|---|---|---|
| Diagnostic Target | Entire HBB gene (coding + regulatory regions) in both parents and fetus | Quantification of hemoglobin A, A2, F – no DNA analysis |
| Detection Rate | >99% of causative mutations, including rare UAE‑specific variants | ~80% carrier detection; misses silent mutations & alpha‑thal interactions |
| Methodology | Sanger Sequencing (Gold Standard), ISO 9001:2015 compliant | Capillary electrophoresis (HPLC) |
| Turnaround Time | 8–10 days | 2–3 days |
| Clinical Utility | Preconception risk stratification, prenatal decision‑making, preimplantation genetic testing planning | Initial screening only; needs reflex DNA test |
Physician Insight & Safety Protocol
“As a DHA‑licensed obstetrician and geneticist, I emphasize that no single laboratory result should be interpreted in isolation. The Beta Thalassemia HBB Trio Analysis provides crucial data, but it must be correlated with complete blood count, hemoglobin electrophoresis, and clinical family history. A non‑pathogenic variant does not wholly exclude the possibility of a fetal hemoglobinopathy, and genetic counselling is mandatory before any reproductive decision.”
— Dr. PRABHAKAR REDDY, DHA Licence 61713011
⚠️ Important Medication Safety Notice
Do not discontinue prescribed medication (iron chelators, folic acid, etc.) without explicit consultation with your treating physician. Genetic test results must not override existing treatment plans.
Exclusion Criteria & Emergency Red Flags
- Severe maternal anemia (Hb <7 g/dL) or hemodynamic instability – emergency care first.
- Active infection at proposed puncture site (amniocentesis/CVS) – postpone collection.
- Unexplained vaginal bleeding or ruptured membranes in pregnancy – immediate ER visit.
- Fetal distress signs: decreased movement, abnormal Doppler – refer to fetal medicine unit.
- Known coagulopathy or anticoagulant therapy without clearance – high risk procedure.
Frequently Asked Questions & Clinical Guidance
What is the Beta Thalassemia HBB Full Gene Trio Analysis?
This comprehensive genetic test sequences the entire HBB gene in both parents and the fetus to detect any pathogenic mutation responsible for beta‑thalassemia.
Direct Clinical Answer: It simultaneously screens the HBB coding and splice‑site regions in maternal, paternal, and fetal DNA, revealing homozygous, compound heterozygous, or trait status with near‑complete sensitivity.
ما هو تحليل الجين HBB الكامل لبيتا ثلاسيميا (ثلاثي)؟
يقوم هذا الاختبار الجيني الشامل بتسلسل جين HBB بالكامل في الوالدين والجنين معًا للكشف عن أي طفرة مسببة لمرض بيتا ثلاسيميا.
الجواب السريري المباشر: يفحص في آنٍ واحد المناطق المشفرة ومواقع التوصيل لجين HBB لدى الأم والأب والحميل، محددًا الحالة المتماثلة أو المركبة المتغايرة أو السليمة بحساسية تشخيصية تقارب 100%.
Who should consider this trio prenatal in the UAE?
Couples with a family history of beta‑thalassemia, consanguineous marriages, or abnormal hemoglobin electrophoresis should pursue this trio analysis for definitive risk assessment.
Critical Guidance: It is recommended for all at‑risk couples early in pregnancy (before 12 weeks) to allow time for genetic counselling and informed options under UAE law, which permits termination for severe fetal anomalies within specified gestational limits.
من الذي ينبغي له إجراء هذا الاختبار الثلاثي قبل الولادة في الإمارات؟
ينبغي للأزواج الذين لديهم تاريخ عائلي لبيتا ثلاسيميا أو زواج الأقارب أو نتائج غير طبيعية في الهيموغلوبين الكهربائي إجراء هذا التحليل الثلاثي.
توجيه أساسي: يُوصى به لجميع الأزواج المعرضين للخطر في بداية الحمل (قبل 12 أسبوعًا) لإتاحة الوقت الكافي للاستشارة الوراثية والخيارات المستنيرة وفق القانون الإماراتي الذي يسمح بإنهاء الحمل في حالات التشوهات الجنينية الشديدة ضمن حدود محددة.
How is the sample collected and is it safe for the pregnancy?
Our DHA‑licensed mobile team collects amniotic fluid or chorionic villi under ultrasound guidance, using strict aseptic technique with a risk of procedure‑related miscarriage <0.1%.
Safety Assurance: The home collection is performed by experienced obstetric sonographers adhering to UAE Federal Decree‑Law No. 41 of 2024 and CDS Law 2026 protocols; emergency backup is available 24/7 through +971545488731.
Regulatory Compliance
🇦🇪 UAE Federal Decree‑Law No. 41 of 2024 (Article 87), Clinical Data Security Law (Minors) 2026, and UAE PDPL (Personal Data Protection Law).
🩺 ISO 9001:2015 Certified – Cert. No: INT/EGQ/2509DA/3139
🏛️ DHA Facility Licence: 9834453
Clinical Guidelines
ICD‑10‑CM 2026: D56.1 Beta thalassemia, D56.3 Thalassemia trait, Z14.8 Genetic susceptibility to other disease
LOINC: 55233‑1 (HBB gene mutations found) – LOINC.org
Methodology: Sanger Sequencing (Gold Standard), ISO accredited sample processing
For pathological correlation, consult Dr. Reddy or your treating specialist.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians